Traditionally, surgeons have reserved transscleral cyclophotocoagulation for instances of superior glaucoma in which maximal medical therapy is insufficient to manage the IOP. Appropriate candidates for the process encompass patients in whom a couple of filtering surgeries have failed, these deemed to be at high danger for complications after or the failure of filtering surgical treatment (eg, people with aphakic glaucoma, neovascular glaucoma, or glaucoma after penetrating keratoplasty), and sufferers with low visible doable for whom an invasive manner is not reasonable.